# Kyntra Bio, Inc.: Form 8-K, filed Feb 20, 2025

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2025-02-20
- Accepted by EDGAR: Feb 20, 2025, 12:00 ET
- Period: 2025-02-19
- Accession: 0000950170-25-023729
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000095017025023729/fgen-20250219.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000095017025023729/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000095017025023729/fgen-20250219.htm

Filed Feb 20, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-023729. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.